Related Experiment Video
Updated: Jul 4, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications
Somjot S Brar1, George Syros, George Dangas
1Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, New York 10032, USA.
Insights
Coronary artery bypass grafting (CABG) was historically standard for multivessel coronary artery disease. Percutaneous revascularization with drug-eluting stents is increasingly challenging CABG, with ongoing trials comparing their efficacy.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Surgery
Background:
- Multivessel coronary artery disease involves multiple coronary arteries or the unprotected left main.
- Revascularization strategy choice is critical for patient outcomes.
- Coronary artery bypass grafting (CABG) has been the traditional treatment.
Purpose of the Study:
- To review the current literature on revascularization strategies for multivessel coronary artery disease.
- To discuss the evolving role of percutaneous coronary intervention (PCI) versus CABG.
- To highlight ongoing research and future directions in managing this condition.
Main Methods:
- Review of existing randomized clinical trials and literature.
- Analysis of comparative studies between CABG and percutaneous revascularization techniques.
- Discussion of advancements in interventional cardiology.
Main Results:
- Early trials favored CABG over medical therapy.
- Trials comparing CABG to bare-metal stenting did not demonstrate a mortality benefit for CABG.
- Advancements in PCI, particularly with drug-eluting stents, are shifting treatment paradigms.
Conclusions:
- The standard of care for multivessel coronary artery disease is evolving.
- Drug-eluting stents present a significant alternative to CABG.
- Ongoing trials comparing CABG to drug-eluting stents will clarify optimal revascularization strategies.
Abstract:
Multivessel coronary artery disease is characterized by involvement of greater than 1 epicardial coronary artery or the unprotected left main. The choice of revascularization strategy in this setting remains a critical issue in cardiology. Although coronary artery bypass grafting has traditionally been the revascularization strategy for most patients with multivessel disease, there has been a gradual shift toward percutaneous revascularization. Early randomized clinical trials showed coronary artery bypass grafting to be superior to medical therapy. However, trials comparing coronary artery bypass grafting to bare metal stenting have not shown a mortality benefit. Advancements in interventional techniques will continue to challenge the notion that coronary artery bypass grafting is the standard therapy for patients with multivessel coronary disease. Several ongoing randomized clinical trials comparing coronary artery bypass grafting to drug-eluting stents will provide valuable insight into the role of each procedure. In this article, we review the existing literature and discuss future directions in the management of the patient with multivessel disease.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease V: Postoperative Nursing Management
